Sanofi/GlaxoSmithKline Covid-19 vaccine enters final trials

The firms have launched a large phase 3 trial enrolling 35,000 adult volunteers (Andrew Matthews/PA)
The firms have launched a large phase 3 trial enrolling 35,000 adult volunteers (Andrew Matthews/PA)

Already a subscriber? Sign in

[[title]]

[[text]]